China Resources Pharmaceutical Group Limited Share Price
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.800 HKD | +0.84% |
|
-0.21% | +7.87% |
| 22/07 | China Resources Pharma Unit Sells 1 Billion Yuan Bonds | MT |
| 16/07 | China Resources Pharma Unit Emerges Top Bidder for Lier Chemical Stake | MT |
| Market Cap | 2.99TCr 381.33Cr 334.92Cr 311.47Cr 285.81Cr 537.02Cr 37TCr 545.3Cr 3.7TCr 1.45TCr 18TCr 1.43TCr 1.4TCr 62TCr | P/E 2026 * |
6.05x | P/E 2027 * | 5.66x |
|---|---|---|---|---|---|
| Enterprise Value | 8.38TCr 1.07TCr 938.89Cr 873.15Cr 801.23Cr 1.51TCr 1,02900Cr 1.53TCr 10TCr 4.05TCr 51TCr 4.01TCr 3.93TCr 1,75000Cr | EV / Sales 2026 * |
0.26x | EV / Sales 2027 * | 0.23x |
| Free-Float |
29.17% | Yield 2026 * |
4.35% | Yield 2027 * | 4.74% |
| 1 day | +0.84% | ||
| 1 week | -0.21% | ||
| Current month | +13.21% | ||
| 1 month | +8.84% | ||
| 3 months | -9.26% | ||
| 6 months | +4.35% | ||
| Current year | +7.87% |
| 1 week | 4.72 |  | 4.93 |
| 1 month | 4.22 | | 4.93 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 20/06/2016 |
Xiao Song Bai
CHM | Chairman | 55 | 29/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/04/20 | Other | Chief Executive Officer | 2,00,000 | 0.0032% | ||
| 31/03/20 | Other | Chief Executive Officer | 1,00,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.84% | -0.21% | -14.29% | -22.58% | 381.33Cr | |
| +0.86% | +1.43% | +47.17% | +163.68% | 1,06700Cr | |
| +1.59% | +4.09% | +56.51% | +52.50% | 63TCr | |
| +0.95% | +1.91% | +36.30% | +82.78% | 46TCr | |
| +1.37% | +8.56% | +38.18% | +32.17% | 35TCr | |
| +1.40% | +4.48% | +37.80% | +41.73% | 30TCr | |
| +1.48% | +3.54% | +18.80% | +19.79% | 26TCr | |
| +1.01% | -1.40% | -28.32% | -39.23% | 22TCr | |
| +1.22% | +2.66% | +22.66% | +59.87% | 20TCr | |
| -1.18% | -3.70% | +11.28% | +67.52% | 16TCr | |
| Average | +0.81% | +1.30% | +22.61% | +45.82% | 36.47TCr | |
| Weighted average by Cap. | +0.78% | +1.95% | +36.30% | +79.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33TCr 4.16TCr 3.65TCr 3.4TCr 3.12TCr 5.85TCr 4,00400Cr 5.95TCr 40TCr 16TCr 1,96800Cr 16TCr 15TCr 6,80500Cr | 34TCr 4.37TCr 3.84TCr 3.57TCr 3.28TCr 6.16TCr 4,20900Cr 6.25TCr 42TCr 17TCr 2,06900Cr 16TCr 16TCr 7,15500Cr |
| Net income | 484.58Cr 62Cr 54Cr 50Cr 46Cr 87Cr 5.95TCr 88Cr 599.33Cr 234.15Cr 2.93TCr 231.97Cr 226.97Cr 10TCr | 524.33Cr 67Cr 59Cr 55Cr 50Cr 94Cr 6.44TCr 96Cr 648.49Cr 253.36Cr 3.17TCr 250.99Cr 245.58Cr 11TCr |
| Net Debt | 5.39TCr 687.66Cr 603.97Cr 561.68Cr 515.41Cr 968.42Cr 66TCr 983.35Cr 6.67TCr 2.61TCr 33TCr 2.58TCr 2.53TCr 1,12600Cr | 4.85TCr 618.61Cr 543.33Cr 505.28Cr 463.66Cr 871.18Cr 60TCr 884.61Cr 6TCr 2.34TCr 29TCr 2.32TCr 2.27TCr 1,01300Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | HK$4.800 | +0.84% | 24,21,260 |
| 24/26/24 | HK$4.760 | -2.06% | 79,51,330 |
| 23/26/23 | HK$4.860 | +1.67% | 88,36,566 |
| 22/26/22 | HK$4.780 | +0.21% | 64,73,832 |
| 21/26/21 | HK$4.770 | -0.83% | 62,64,370 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
